Crossmark

Aortic rupture following acute aortitis in a patient with head and neck carcinoma treated with nivolumab: a rare but severe immune-related adverse event

Crossref DOI link: https://doi.org/10.1007/s00405-024-08495-2

Published Online: 2024-02-03

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ohno, Yuki

Ueki, Yushi https://orcid.org/0000-0002-1699-7891
Oshima, Shusuke

Omata, Jo

Yokoyama, Yusuke

Takahashi, Takeshi

Shodo, Ryusuke

Yamazaki, Keisuke

Horii, Arata
License Information

Text and Data Mining valid from 2024-02-03

Version of Record valid from 2024-02-03
More Information

Article History

Received: 3 November 2023

Accepted: 22 January 2024

First Online: 3 February 2024

Declarations

:

: None declared.

: This study was conducted in accordance with the principles of the Declaration of Helsinki. The patients provided their written informed consent to participate in this study.

Document is current

Any future updates will be listed below